FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2516528078> ?p ?o ?g. }

• W2516528078 endingPage "57" @default.
• W2516528078 startingPage "47" @default.
• W2516528078 abstract "Severe acute kidney injury requiring continuous renal replacement therapy is associated with a high risk of early mortality. Our objectives were to identify a cohort of early survivors and to follow their renal progress and long-term mortality.Multicenter, observational, retrospective cohort study.ICUs in tertiary academic hospitals in Korea.From 2009 to 2013, we identified 1,764 severe acute kidney injury patients who were started on continuous renal replacement therapy at four hospitals. Of these, we identified 331 survivors for whom we could identify renal function at baseline and at 3 months.None.The 331 patients were separated into two groups based on their renal function at 3 months after the start of continuous renal replacement therapy. Those who displayed significant deterioration in renal function compared to baseline, defined as greater than or equal to 50% increase in serum creatinine or greater than or equal to 35% decrease in the estimated glomerular filtration rate, or those who continued to receive renal replacement therapy were designated as a 3-month chronic kidney disease progression group. Those with a return to baseline, less than 50% increase in serum creatinine or less than 35% decrease in the estimated glomerular filtration rate, were designated as a 3-month chronic kidney disease nonprogression group. The acute kidney injury patients requiring continuous renal replacement therapy showed a higher risk of progression to end-stage renal disease compared to that of stage 3 chronic kidney disease patients who did not undergo an acute kidney injury episode, even if the acute kidney injury was recovered at 3 months after continuous renal replacement therapy initiation. Furthermore, 3-month chronic kidney disease progression was associated with a high risk of progression to end-stage renal disease and long-term mortality over a median follow-up period of 12.7 (3.8-33.2) and 20.4 (7.5-39.7) months, respectively. Older age, higher baseline serum creatinine levels, and higher blood urea nitrogen concentrations at continuous renal replacement therapy initiation, and lower 24-hour urine output after continuous renal replacement therapy initiation are associated with an increased risk of 3-month chronic kidney disease progression.Renal functional assessment at 3 months after continuous renal replacement therapy initiation can be useful in predicting progression to end-stage renal disease and long-term mortality. Furthermore, continuous close monitoring and management of acute kidney injury patients requiring continuous renal replacement therapy are required, even in those with recovered renal function." @default.
• W2516528078 created "2016-09-16" @default.
• W2516528078 creator A5009535032 @default.
• W2516528078 creator A5021592381 @default.
• W2516528078 creator A5022646032 @default.
• W2516528078 creator A5033449275 @default.
• W2516528078 creator A5037799824 @default.
• W2516528078 creator A5053562128 @default.
• W2516528078 creator A5066672164 @default.
• W2516528078 creator A5069468397 @default.
• W2516528078 creator A5075976531 @default.
• W2516528078 creator A5083042968 @default.
• W2516528078 creator A5085491969 @default.
• W2516528078 date "2017-01-01" @default.
• W2516528078 modified "2023-10-18" @default.
• W2516528078 title "Chronic Kidney Disease After Acute Kidney Injury Requiring Continuous Renal Replacement Therapy and Its Impact on Long-Term Outcomes" @default.
• W2516528078 cites W1561229456 @default.
• W2516528078 cites W1950965405 @default.
• W2516528078 cites W1976973072 @default.
• W2516528078 cites W1977631882 @default.
• W2516528078 cites W1980336273 @default.
• W2516528078 cites W1980448293 @default.
• W2516528078 cites W1982104585 @default.
• W2516528078 cites W1984294182 @default.
• W2516528078 cites W1985641253 @default.
• W2516528078 cites W1986757620 @default.
• W2516528078 cites W1991880201 @default.
• W2516528078 cites W1994205207 @default.
• W2516528078 cites W1999577714 @default.
• W2516528078 cites W2000445173 @default.
• W2516528078 cites W2004993841 @default.
• W2516528078 cites W2011112825 @default.
• W2516528078 cites W2014476441 @default.
• W2516528078 cites W2023521161 @default.
• W2516528078 cites W2030399183 @default.
• W2516528078 cites W2031384622 @default.
• W2516528078 cites W2036168672 @default.
• W2516528078 cites W2051157896 @default.
• W2516528078 cites W2051338691 @default.
• W2516528078 cites W2071612590 @default.
• W2516528078 cites W2079079821 @default.
• W2516528078 cites W2088427111 @default.
• W2516528078 cites W2098722533 @default.
• W2516528078 cites W2102132939 @default.
• W2516528078 cites W2116900376 @default.
• W2516528078 cites W2119724914 @default.
• W2516528078 cites W2131180446 @default.
• W2516528078 cites W2131419242 @default.
• W2516528078 cites W2135163018 @default.
• W2516528078 cites W2135765082 @default.
• W2516528078 cites W2141701308 @default.
• W2516528078 cites W2149687213 @default.
• W2516528078 cites W2152249969 @default.
• W2516528078 cites W2155441599 @default.
• W2516528078 cites W2326903775 @default.
• W2516528078 cites W4246250719 @default.
• W2516528078 doi "https://doi.org/10.1097/ccm.0000000000002012" @default.
• W2516528078 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27565014" @default.
• W2516528078 hasPublicationYear "2017" @default.
• W2516528078 type Work @default.
• W2516528078 sameAs 2516528078 @default.
• W2516528078 citedByCount "24" @default.
• W2516528078 countsByYear W25165280782017 @default.
• W2516528078 countsByYear W25165280782018 @default.
• W2516528078 countsByYear W25165280782019 @default.
• W2516528078 countsByYear W25165280782020 @default.
• W2516528078 countsByYear W25165280782021 @default.
• W2516528078 countsByYear W25165280782022 @default.
• W2516528078 crossrefType "journal-article" @default.
• W2516528078 hasAuthorship W2516528078A5009535032 @default.
• W2516528078 hasAuthorship W2516528078A5021592381 @default.
• W2516528078 hasAuthorship W2516528078A5022646032 @default.
• W2516528078 hasAuthorship W2516528078A5033449275 @default.
• W2516528078 hasAuthorship W2516528078A5037799824 @default.
• W2516528078 hasAuthorship W2516528078A5053562128 @default.
• W2516528078 hasAuthorship W2516528078A5066672164 @default.
• W2516528078 hasAuthorship W2516528078A5069468397 @default.
• W2516528078 hasAuthorship W2516528078A5075976531 @default.
• W2516528078 hasAuthorship W2516528078A5083042968 @default.
• W2516528078 hasAuthorship W2516528078A5085491969 @default.
• W2516528078 hasConcept C126322002 @default.
• W2516528078 hasConcept C126894567 @default.
• W2516528078 hasConcept C141071460 @default.
• W2516528078 hasConcept C159641895 @default.
• W2516528078 hasConcept C167135981 @default.
• W2516528078 hasConcept C2778653478 @default.
• W2516528078 hasConcept C2779541074 @default.
• W2516528078 hasConcept C2780091579 @default.
• W2516528078 hasConcept C2780306776 @default.
• W2516528078 hasConcept C2780472472 @default.
• W2516528078 hasConcept C54847362 @default.
• W2516528078 hasConcept C71924100 @default.
• W2516528078 hasConceptScore W2516528078C126322002 @default.
• W2516528078 hasConceptScore W2516528078C126894567 @default.
• W2516528078 hasConceptScore W2516528078C141071460 @default.
• W2516528078 hasConceptScore W2516528078C159641895 @default.
• W2516528078 hasConceptScore W2516528078C167135981 @default.
• W2516528078 hasConceptScore W2516528078C2778653478 @default.

• next